X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Medicare Monday: 3 reasons why repealing Part D’s noninterference clause is a bad idea

By Nicole Longo  |    June 26, 2017
A number of proposals have been thrown around as part of the health care debate. One idea is to repeal the noninterference clause in Medicare Part D. Doing so would allow the Secretary of Health...   Read More

Medicare Monday: How government price setting in Part D could reduce innovation, shorten life expectancy for beneficiaries

By Nicole Longo  |    June 19, 2017
Today, we are diving into the conversation about how government price setting proposals could impact the Medicare Part D program and beneficiaries. Imposing Veterans Administration (VA)-style...   Read More

Medicare Monday: Positive impact of Part D on America’s seniors

By Nicole Longo  |    June 5, 2017
Implementation of Medicare Part D significantly increased access to medicines for seniors and for those under age 65 with permanent disabilities. Since then, Part D has contributed to significant...   Read More

Medicare Monday: Why imposing Medicaid-style rebates in Part D is a bad idea

By Nicole Longo  |    May 15, 2017
We’ve talked a lot about how repealing the non-interference clause in Medicare Part D would negatively impact beneficiaries. But there are other proposals to fundamentally alter the structure of...   Read More

Medicare Monday: Another example of the competitive market at work in Part D

By Nicole Longo  |    April 17, 2017
Hepatitis C is a devastating viral disease that can result in life-threatening and costly complications. Five years ago, the only available treatment for the disease often resulted in debilitating...   Read More

Medicare Monday: A discussion on affordability and access to medicines

By Nicole Longo  |    March 27, 2017
In case you missed it, the American Society on Aging held its annual conference last week in Chicago, IL, where Lori Reilly, PhRMA executive vice president of policy, research & membership, spoke...   Read More

Medicare Monday: New study further confirms increased use of generics after Part D

By Nicole Longo  |    March 6, 2017
On Medicare Monday, we’ve talked a lot about how things have changed since 2006 and the implementation of Part D. We’ve looked at how Part D costs less than originally projected, how premiums have...   Read More

Medicare Monday: Did you know … ?

By Nicole Longo  |    February 6, 2017
On Medicare Monday, we talk a lot about Medicare Part D and how it works, but here are five things you might not know about the program.   Read More

Medicare Monday: How Part D helps patients with heart disease live longer, healthier lives

By Nicole Longo  |    January 30, 2017
Wednesday kicks off American Heart Month, so this week we’re looking at heart health and how important it is for patients to have access to needed medicines for heart disease and stroke. This is...   Read More

Medicare Monday: How Medicare helps beneficiaries access needed medicines

By Nicole Longo  |    January 23, 2017
Throughout 2016, we looked at how different groups of beneficiaries – from seniors to minority communities to individuals with lower-incomes – rely on Medicare to access their needed prescription...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates